Tuesday, January 29, 2008

Just when you thought we were through with Ketex

I have ranted about various aspects of the Ketex saga before-fatal liver side effects and bogus clinical trial data and a major thought leader enabled , pseudo-CME, hyped up, thinly disguised advertisement campaign for a medication which, in my humble opinion, served no rational purpose in a doc's antibiotic quiver.

Now a House Panel is busy looking into some of the "data integrity " problems that would appear to be mainly yesterday's news but now apparently the FDA is being accused of not supplying material for an House subcommittee investigation investigation. See here for some thoughts on how bad the integrity problem was and here for a WSJ blog article on the House activities in that regard.

No comments: